Core & Main
CNM
40.70
-1.40
-3.33%
Core & Main
US · CNM
#1683 by market cap
Listed 2021
40.70
-1.40
-3.33%
Live - 5344 symbols - heartbeat 424s ago
· 2026-10-08 04:01
Pre-market
40.70
0.00%
After-hours
40.70
0.00%
- Market cap
- 7.50B
- P/E (TTM)i
- 16.75
- P/Bi
- 3.69
- EPSi
- 2.31
- Div yieldi
- 0.00%
- 52W posi
- 6%
Reader sentiment
Are you bullish or bearish on CNM?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 3.22, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +2.77% YoY
Margins
- Gross margin
- 26.93%
- Operating margin
- 9.44%
- Net margin
- 5.77%
Key ratios & quality
- Enterprise valuei
- 9.50B
- PEG ratioi
- 2.61
- Altman Z-Scorei
- 3.22
PEG uses trailing P/E against the 3-year net income growth rate (6.41%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 3.20B | 3.39B | 3.64B | 5.00B | 6.65B | 6.70B | 7.44B | 7.65B |
| Gross profit | 708.10M | 789.00M | 878.00M | 1.28B | 1.80B | 1.82B | 1.98B | 2.06B |
| Selling & admin expenses | 457.70M | 509.00M | 556.00M | 717.00M | 880.00M | 931.00M | 1.08B | 1.15B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 138.40M | 155.00M | 185.00M | 425.00M | 775.00M | 740.00M | 719.00M | 722.00M |
| Pretax profit | 37.30M | 42.00M | 46.00M | 276.00M | 709.00M | 659.00M | 577.00M | 607.00M |
| Tax | 700.00K | 6.00M | 9.00M | 51.00M | 128.00M | 128.00M | 143.00M | 145.00M |
| Net profit | 36.60M | 36.00M | 37.00M | 225.00M | 581.00M | 531.00M | 434.00M | 462.00M |
| Basic EPS | 0 | 0 | 0 | 1 | 2 | 2 | 2 | 2 |
| Diluted EPS | 0.15 | 0.15 | 0.15 | 0.55 | 2.13 | 2.15 | 2.13 | 2.31 |
| Line item | 2025-05 | 2025-08 | 2025-11 | 2026-01 | 2026-05 | 2026-08 |
|---|---|---|---|---|---|---|
| Revenue | 1.91B | 2.09B | 2.06B | 1.58B | 1.91B | 2.15B |
| Gross profit | 510.00M | 560.00M | 561.00M | 428.00M | 520.00M | 573.00M |
| Selling & admin expenses | 293.00M | 302.00M | 295.00M | 264.00M | 299.00M | 301.00M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 171.00M | 213.00M | 220.00M | 118.00M | 177.00M | 227.00M |
| Pretax profit | 141.00M | 182.00M | 190.00M | 94.00M | 150.00M | 193.00M |
| Tax | 36.00M | 41.00M | 47.00M | 21.00M | 37.00M | 43.00M |
| Net profit | 105.00M | 141.00M | 143.00M | 73.00M | 113.00M | 150.00M |
| Basic EPS | 1 | 1 | 1 | 0 | 1 | 1 |
| Diluted EPS | 0.52 | 0.70 | 0.72 | 0.37 | 0.57 | 0.77 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | -- | 1.04B | 1.34B | 1.77B | 2.21B | 1.77B | 2.03B | 2.30B |
| Cash & ST investments | -- | 180.90M | 381.00M | 1.00M | 177.00M | 1.00M | 8.00M | 220.00M |
| Inventory | -- | 336.10M | 384.00M | 856.00M | 1.05B | 766.00M | 908.00M | 986.00M |
| Total assets | -- | 3.20B | 3.92B | 4.43B | 4.91B | 5.07B | 5.87B | 6.09B |
| Total current liabilities | -- | 430.40M | 522.00M | 839.00M | 726.00M | 774.00M | 866.00M | 874.00M |
| Short-term debt | -- | 52.80M | 56.00M | 64.00M | 69.00M | 70.00M | 91.00M | 99.00M |
| Long-term debt | -- | 2.01B | 2.25B | 1.46B | 1.44B | 1.86B | 2.24B | 2.12B |
| Total liabilities | -- | 2,557,900,000.00 | 3,123,000,000.00 | 2,603,000,000.00 | 2,499,000,000.00 | 3,545,000,000.00 | 4,096,000,000.00 | 4,011,000,000.00 |
| Total equity | -- | 641.50M | 801.00M | 1.83B | 2.41B | 1.52B | 1.77B | 2.07B |
| Retained earnings | -- | -- | 0 | 92.00M | 458.00M | 189.00M | 449.00M | 755.00M |
| Line item | 2025-05 | 2025-08 | 2025-11 | 2026-01 | 2026-05 | 2026-08 |
|---|---|---|---|---|---|---|
| Total current assets | 2.44B | 2.51B | 2.51B | 2.30B | 2.56B | 2.94B |
| Cash & ST investments | 8.00M | 25.00M | 89.00M | 220.00M | 150.00M | 312.00M |
| Inventory | 1.07B | 1.06B | 1.02B | 986.00M | 1.10B | 1.14B |
| Total assets | 6.28B | 6.31B | 6.30B | 6.09B | 6.32B | 6.71B |
| Total current liabilities | 1.25B | 1.12B | 1.11B | 874.00M | 1.11B | 1.19B |
| Short-term debt | 94.00M | 97.00M | 98.00M | 99.00M | 101.00M | 96.00M |
| Long-term debt | 2.24B | 2.23B | 2.13B | 2.12B | 2.12B | 2.43B |
| Total liabilities | 4,457,000,000.00 | 4,344,000,000.00 | 4,245,000,000.00 | 4,011,000,000.00 | 4,210,000,000.00 | 4,605,000,000.00 |
| Total equity | 1.82B | 1.96B | 2.06B | 2.07B | 2.11B | 2.10B |
| Retained earnings | 515.00M | 642.00M | 736.00M | 755.00M | 786.00M | 784.00M |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 100.90M | 194.00M | 214.00M | -31.00M | 401.00M | 1.07B | 621.00M | 650.00M |
| Depreciation & amortization | 122.30M | 138.00M | 153.00M | 150.00M | 148.00M | 154.00M | 194.00M | 192.00M |
| Free cash flow | 87.00M | 180.00M | 202.00M | -51.00M | 376.00M | 1.03B | 586.00M | 604.00M |
| Dividends paid | -25.40M | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | 0 | 0 | 664.00M | 0 | -1.34B | -176.00M | -155.00M |
| Ending cash balance | 37.30M | 181.00M | 381.00M | 1.00M | 177.00M | 1.00M | 8.00M | 220.00M |
| Line item | 2025-05 | 2025-08 | 2025-11 | 2026-01 | 2026-05 | 2026-08 |
|---|---|---|---|---|---|---|
| Operating cash flow | 77.00M | 34.00M | 271.00M | 268.00M | 82.00M | 62.00M |
| Depreciation & amortization | 48.00M | 48.00M | 48.00M | 48.00M | 47.00M | 50.00M |
| Free cash flow | 64.00M | 24.00M | 263.00M | 253.00M | 68.00M | 44.00M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -39.00M | -8.00M | -50.00M | -58.00M | -88.00M | -169.00M |
| Ending cash balance | 8.00M | 25.00M | 89.00M | 220.00M | 150.00M | 312.00M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -- | 5.61 | 6.77 | 16.61 | 23.83 | 23.20 | 26.10 | 23.87 |
| ROA %i | -- | 1.13 | 1.31 | 4.14 | 7.83 | 7.44 | 7.51 | 7.38 |
| ROIC %i | -- | 4.76 | 6.08 | 8.17 | 13.27 | 12.64 | 13.40 | 12.33 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | 14.68 | 18.78 | 22.52 |
| EBIT margin %i | 4.32 | 4.57 | 5.09 | 7.47 | 11.65 | 11.04 | 9.66 | 9.51 |
| FCF / sales %i | 2.72 | 5.31 | 5.71 | -- | 5.65 | 15.37 | 7.88 | 7.90 |
| Current ratioi | -- | 2.41 | 2.56 | 2.11 | 3.05 | 2.29 | 2.34 | 2.63 |
| Quick ratioi | -- | 1.59 | 1.80 | 1.05 | 1.56 | 1.26 | 1.24 | 1.45 |
| Debt / assetsi | -- | 67.12 | 61.01 | 36.60 | 33.29 | 40.86 | 42.69 | 40.05 |
| LT debt / equityi | -- | 326.53 | 291.89 | 117.66 | 89.58 | 137.90 | 142.23 | 117.08 |
| Interest coveragei | 1.37 | 1.37 | 1.33 | 3.82 | 11.74 | 9.14 | 5.06 | 6.06 |
| Revenue CAGR (3Y) %i | -- | -- | -- | 16.05 | 25.20 | 22.54 | 14.14 | 4.76 |
| Net income CAGR (3Y) %i | -- | -- | -- | 65.53 | 116.63 | 115.64 | 35.28 | 6.41 |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | 27.83 | 72.12 | -- | 17.12 |
| Line item | 2025-05 | 2025-08 | 2025-11 | 2026-01 | 2026-05 | 2026-08 |
|---|---|---|---|---|---|---|
| ROE %i | 25.11 | 24.42 | 23.85 | 23.87 | 23.73 | 23.44 |
| ROA %i | 6.75 | 6.95 | 6.95 | 7.38 | 7.13 | 7.05 |
| ROIC %i | 12.26 | 12.23 | 12.20 | 12.33 | 12.29 | 11.94 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 9.49 | 9.44 | 9.38 | 9.51 | 9.59 | 9.68 |
| FCF / sales %i | 7.61 | 7.29 | 7.41 | 7.90 | 7.95 | 8.16 |
| Current ratioi | 1.96 | 2.25 | 2.26 | 2.63 | 2.31 | 2.47 |
| Quick ratioi | 1.07 | 1.24 | 1.29 | 1.45 | 1.27 | 1.47 |
| Debt / assetsi | 40.28 | 40.18 | 38.63 | 40.05 | 38.65 | 40.97 |
| LT debt / equityi | 139.62 | 129.22 | 118.16 | 117.08 | 114.85 | 130.63 |
| Interest coveragei | 5.23 | 5.50 | 5.73 | 6.06 | 6.26 | 6.31 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Pipes, valves & fittings products is the largest reported line at 68.11% of revenue, across 4 reported segments.
- Storm drainage products follows at 15.57%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Pipes, valves & fittings products68.11%
Storm drainage products15.57%
Fire protection products8.21%
Smart utility products8.11%
Quote time 2026-10-08 04:01:04 · For reference only, not investment advice and not tailored to your situation.